Cargando…

Vonoprazan‐associated long QT syndrome

To our knowledge, this is the first report describing a case of vonoprazan‐associated QT prolongation newly occurring after initiation of the drug and improving after its discontinuation in a patient concurrently receiving polypharmacy including a drug metabolized by CYP3A4.[Image: see text]

Detalles Bibliográficos
Autores principales: Kubo, Kimitoshi, Sakakibara, Toru, Yonezawa, Kazuya, Kato, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721332/
https://www.ncbi.nlm.nih.gov/pubmed/35004113
http://dx.doi.org/10.1002/jgf2.485

Ejemplares similares